Cancer Research UK logo.
SearchDonate
  • Search

A study of PDR001 in combination with other drugs for advanced cancer

Overview

Cancer types:

Bowel (colorectal) cancer, Breast cancer, Kidney cancer, Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Closed

Phase:

Phase 1

Details

This study is combining PDR001 with other drugs for cancer that has spread to the nearby tissue (locally advanced) or to another part of the body (metastatic).

This study is for people with:

  • bowel cancer

  • triple negative breast cancer

  • kidney cancer

  • non small cell lung cancer

Recruitment start: 14 October 2016

Recruitment end: 15 December 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Udai Banerji

Supported by

Novartis

Last reviewed: 15 December 2020

CRUK internal database number: 16143

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.